High-Throughput Screening of Amyloid Inhibitors via Covalent-Labeling Mass Spectrometry
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.4c06418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Kanitin Khamnong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States. Hauptthemen laut MEDLINE: High-Throughput Screening Assays, Mass Spectrometry, Amyloid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Army Research Office, Institute for the Promotion of Teaching Science and Technology.
Abstract (Originalsprache)
Amyloid fibril formation by proteins is implicated in numerous human diseases, yet few treatments exist in part due to the lack of robust screening methods for amyloid inhibitors. Here, we demonstrate a novel mass spectrometry (MS) assay for high-throughput screening of amyloid inhibitors, based on measuring the extent of protein labeling during protein aggregation. Amyloid formation decreases covalent labeling (CL) extents, while the presence of an inhibitor restores the extent of labeling, providing a means of identifying inhibitors. Using two different labeling reagents, α,β-unsaturated carbonyl (ABUC) and diethylpyrocarbonate (DEPC), and insulin and β2-microglobulin (β2m) as model amyloid proteins, we show that the CL-MS assay can probe protein amyloid formation and its inhibition by a wide range of compounds, with validation achieved by comparisons to traditional fluorescence and light scattering techniques. In proof-of-concept screens, several new inhibitors are identified for both proteins and further verified for their ability to fully prevent aggregation. Overall, our CL-MS assay offers fewer false positives than conventional methods and is compatible with high-throughput screening, achieving rates of >10 compounds per minute using matrix-assisted laser desorption/ionization (MALDI)-MS as a readout.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.
- Molecular & Cellular Biology Program, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.
- Center for Bioactive Delivery, Institute for Applied Life Sciences, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.
- Department of Biomedical Engineering, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.
ORCID-Profile: Kanitin Khamnong, S Thayumanavan, Richard W Vachet
Förderung
- NIGMS NIH HHS
- Army Research Office
- Institute for the Promotion of Teaching Science and Technology
- U.S. Department of Health and Human Services
- Ministry of Higher Education, Science, Research and Innovation, Thailand
Zitieren
APA
Khamnong, K., Stahl, V. L., Izikson, O. N., Devarajan, A., Thayumanavan, S., & Vachet, R. W. (2025). High-Throughput Screening of Amyloid Inhibitors via Covalent-Labeling Mass Spectrometry. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c06418
Vancouver
Khamnong K, Stahl VL, Izikson ON, Devarajan A, Thayumanavan S, Vachet RW. High-Throughput Screening of Amyloid Inhibitors via Covalent-Labeling Mass Spectrometry. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.4c06418
BibTeX
@article{Khamnong2025,
author = {Khamnong, Kanitin and Stahl, Vanessa L and Izikson, Olivia N and Devarajan, Anirudh and Thayumanavan, S and Vachet, Richard W},
title = {High-Throughput Screening of Amyloid Inhibitors via Covalent-Labeling Mass Spectrometry},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.4c06418}
}
EUVIMED